Expanding the scope of noninvasive prenatal testing: Detection of fetal microdeletion syndromes

Ronald J. Wapner, Joshua E. Babiarz, Brynn Levy, Melissa Stosic, Bernhard Zimmermann, Styrmir Sigurjonsson, Nicholas Wayham, Allison Ryan, Milena Banjevic, Phil Lacroute, Jing Hu, Megan P. Hall, Zachary Demko, Asim Siddiqui, Matthew Rabinowitz, Susan J. Gross, Matthew Hill, Peter Benn

Research output: Contribution to journalArticlepeer-review

247 Scopus citations


Objective The purpose of this study was to estimate the performance of a single-nucleotide polymorphism (SNP)-based noninvasive prenatal test for 5 microdeletion syndromes. Study Design Four hundred sixty-nine samples (358 plasma samples from pregnant women, 111 artificial plasma mixtures) were amplified with the use of a massively multiplexed polymerase chain reaction, sequenced, and analyzed with the use of the Next-generation Aneuploidy Test Using SNPs algorithm for the presence or absence of deletions of 22q11.2, 1p36, distal 5p, and the Prader-Willi/Angelman region. Results Detection rates were 97.8% for a 22q11.2 deletion (45/46) and 100% for Prader-Willi (15/15), Angelman (21/21), 1p36 deletion (1/1), and cri-du-chat syndromes (24/24). False-positive rates were 0.76% for 22q11.2 deletion syndrome (3/397) and 0.24% for cri-du-chat syndrome (1/419). No false positives occurred for Prader-Willi (0/428), Angelman (0/442), or 1p36 deletion syndromes (0/422). Conclusion SNP-based noninvasive prenatal microdeletion screening is highly accurate. Because clinically relevant microdeletions and duplications occur in >1% of pregnancies, regardless of maternal age, noninvasive screening for the general pregnant population should be considered.

Original languageEnglish
Pages (from-to)332.e1-332.e9
JournalAmerican Journal of Obstetrics and Gynecology
Issue number3
StatePublished - 1 Mar 2015
Externally publishedYes


  • microdeletion
  • noninvasive prenatal testing
  • singlenucleotide polymorphism


Dive into the research topics of 'Expanding the scope of noninvasive prenatal testing: Detection of fetal microdeletion syndromes'. Together they form a unique fingerprint.

Cite this